产品封面图

免疫级别血蓝蛋白

收藏
  • ¥2000
  • Biosyn
  • 美国
  • Biosyn-56
  • 2025年08月14日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      见说明书

    • 保质期

      3年

    • 英文名

      Keyhole Limpet Hemocyanin (KLH)

    • 库存

      一定库存

    • 供应商

      美国Biosyn公司

    • CAS号

      见说明书

    • 规格

      20mg

    KLH说明书http://biosyncorp.com/immucothelr/
    Biosyn公司简介及产品介绍

    产品细节图片1

    Biosyn公司于1995年创立于美国加州,是一家专业研发和生产高质量的科研级别临床/GMP血蓝蛋白的生物医药公司。目前biosyn公司生产的血蓝蛋白在大型国际医药公司中有约30%的市场占有率。血蓝蛋白来源于大锁孔帽贝(透孔螺)的血淋巴,也被叫做匙孔血蓝蛋白,是具有高度免疫原性的蛋白大分子,也是一种多功能蛋白,它不仅具有输氧功能,而且还与能量的贮存、渗透压的维持及蜕皮过程的调节有关,还具有酚氧化物酶活性和抗菌功能,被认为是节肢动物和软体动物中的一种重要的免疫分子。


    KLH用于疫苗的生产,免疫原的制备KLH广泛作为载体蛋白应用,交联于半抗原和其他抗原,使它们具有更强的免疫原性以用于抗体的制备。由于其质量大,复杂性高,与其他载体蛋白相比KLH会引出更强的免疫应答。因为此蛋白来源于软体动物,它在系统发生上远离哺乳动物物种,在测定过程中产生会与典型靶点样品发生交叉反应的抗体的可能性较小。作为大的蛋白质,KLH含有上百个伯胺和羧基基团可以成为与戊二醛,N-羟基琥珀酰亚胺酯和EDC等交联试剂交联的靶点。

    biosyn Immunocyanin Products
    产品细节图片2
    * HPG = High Purity Grade; RG = Research Grade; CG = Clinical Grade

    1、KLH
    biosyn hemocyanin products

    biosyn is a world leader in the manufacture of high quality, clinical/GMP and research grade hemocyanin products derived from the hemolymph of the sea snail, Meghathura crenulata, also commonly known as the Giant Keyhole Limpet.
    产品细节图片3
    The hemocyanin derived from this snail is known Keyhole Limpet Hemocyanin (KLH).
    .biosyn hemocyanin - first hemocyanin product for the treatment of bladder cancer
    .biosyn hemocyanin and immunocyanin, KLH subunits, as a preferred carrier protein of the conjugate vaccine
    .immunocyanin - high quality - GMP/Clinical grade - Drug Master File
    .biosyn hemocyanin products are eco-friendly
    .Recombinant technology development
    2、KLH/KLH: Keyhole Limpet Hemocyanin产品细节图片4

    KLH: Keyhole Limpet Hemocyanin - biosyn native KLH
    The hemocyanin produced from the hemolymph sera of the marine mollusk Giant Keyhole Limpet, Megathura crenulata, has been in use and marketed as a crude or partially purified product for over 40 years by some chemical companies. This molecule is well recognized and commonly abbreviated as KLH. The crude research grade KLH is used in antibody production in animals against antigens. The animal sera containing the antibody for the antigen are further processed and used as immunological reagents or in immunological assays. The partially purified product has also been used in early human trials for immune status evaluation.

    KLH structure
    The native KLH is a cylindrical copper containing blue protein with a molecular mass ranging from 8-32 MDa (Million Dalton). Electron microscopy structural studies reveal presence of two oligomeric forms:

    .Didecamers with a molecular mass of 8 MDa, are present in the form of hollow cylinders. They are approximately 35 nm in diameter and 40 nm in length.

    .Multidecamers with a molecular mass of 12-32 MDa, present as stacked decamers (multidecamers) of varying length, added on one or both sides of a "nucleating" didecamer. Single decamers exhibit rectangular side views.
    产品细节图片5
    Prof. Dr. Jürgen Markl, Direktor Zoologisches Institut der Johannes Gutenberg-Universität Mainz, Germany

    The didecamer consists of 20 subunits and occurs in two different Isoforms named KLH1 and KLH2. The subunits are biochemically and immunologically distinct. Analysis of KLH by native-PAGE gives two characteristic bands, one corresponding to KLH1 with an apparent molecular mass of about 390 kDa (kilo Dalton) and the other corresponding to KLH2 with an apparent molecular mass of 350 kDa.

    Each subunit of both Isoforms, KLH1 and KLH2, consists of eight paralogous functional units (FU), named 'a' to 'h', whereby the FUs a-f form the wall of the cylinder and g-h build up the collar-complex of the molecule. The molecular mass of the functional units is about 50 kDa. Based on this information it is expected that the molecular masses of the KLH1 and KLH2 subunits are approximately 400 kDa. The functional unit (FU) within the subunit contains a binuclear copper binding site that reversibly binds molecular oxygen.

    The copper is in the cuprous [Cu(I)] state, and oxygen-binding generates light absorbance in the near ultraviolet around 343 nm and imparts the characteristic blue color to the molecule. The deoxygenated molecule is colorless.

    Peptide sequence
    The peptide sequence surrounding the two copper-binding sites is highly conserved, with three copper-liganding histidines in both cases. The active site geometry and molecular architecture of the mollusk hemocyanin differ from those of arthropod hemocyanin.
    Removal of second copper from mollusk hemocyanin by cyanide ions is both slower and more difficult compared to arthropod hemocyanin, where all the copper comes off readily. Further differences between the two hemocyanin subunits are revealed by hydrogen peroxide treatments.

    3、KLH / biosyn native
    KLH
    biosyn native KLH, low enodoxin content
    The high molecular weight, native KLH, is extensively used and has been used over the last several years. Native KLH has been manufactured and supplied by some chemical suppliers.

    However, most available KLH formulations are not of the required quality and consistency suitable for use in human clinical trials. Typically, the endotoxin content in such products is very high as the hemolymph sera production is done by cutting open the animals or extraction from frozen animals. The product characteristics are also not very good and could lead to precipitation during reconstitution of lyophilized KLH. It is well documented that either freezing or lyophilization of native KLH leads to loss in activity.

    Characterization of native KLH is also an issue as the large molecular weight of 8-32 MDa does not allow use of standard biochemical methods for routine quality control, which is further complicated by the use of excessive metal ions like calcium and magnesium, presumably to stabilize the molecule.

    Right from the start of the hemocyanin development work in 1985, biosyn had identified these to be critical issues and developed appropriate strategies to overcome these limitations. To achieve the desired safety, quality and consistency of native KLH, biosyn has developed the non-lethal hemolymph sera collection procedure from live animals and instituted necessary animal handling and quarantine techniques. Quality control methodologies for routine production of this critical raw material has been developed.

    The end result of these technology developments in the animal handling, bleeding and manufacturing process was the production of biosyn low endotoxin and high concentration native KLH of consistent high quality in a phosphate buffer.

    The biosyn native KLH is supplied as High Purity Grade and Research Grade (no endotoxin testing). The GMP grade material is ideally suited for use as a carrier protein in the manufacture of vaccines for human use. It is tested for biological safety, viral clearance and heavy metal ions.

    The Research Grade material is suited for use in vaccine product development activities and also for routine immunological studies, antibody production, production of activated KLH and other developmental activities. The native KLH formulations currently available from biosyn are listed in the table.

    Product

    Grade

    Uses

    Native KLH in Phosphate buffer low endotoxin, tested for biological safety, viral clearance and metal ions

    GMP
    Clinical
    grade

    For further processing in KLH-conjugate vaccine manufacture for human and animal use

    Native KLH in Phosphate buffer, or other buffers low endotoxin

    RG

    Routine immunological and antibody studies and antibody production, initial product development activity for conjugate vaccine. Preparation of Research Grade activated KLH

    Native KLH in Phosphate buffer or other buffers. No endotoxin testing

    RG

    Low cost research grade material for research uses

    RG=Research Grade
    Biosyn公司网址: http://biosyncorp.com/klh/
    中国独家授权代理:
    深圳市华拓生物科技有限公司(
    www.otwobiotech.com
    相关产品:
    血蓝蛋白抗体

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 文献速递:个性化循环肿瘤 DNA 可成为免疫治疗疗效新型biomarker

      研究背景 使用程序性死亡-1抑制剂或其配体(抗PD-1/PD-L1)的免疫检查点阻断 (ICB) 疗法已成为治疗许多癌症的有效方法。然而仅有少数患者对ICB疗法表现出长期良好的反应,大多数患者对免疫检查点阻断剂都没有阳性反应或因为阻断剂的不良反应而不得不停止服用。虽然已经发现了许多类别的生物标志物,但目前仍未发现强有力的治疗反应预测标志物。寻求新的ICB反应的非侵入性生物标志物能大大提高ICB疗法的临床效果。 研究内容及结果 2020年9月,在Nature子刊Nature Cancer

    • AAV 在眼科中的应用

      遗传性眼病是一类由于基因缺陷而导致的疾病,目前已报道大约有 200 种遗传性眼病和超过 400 种具有眼部表现的系统性疾 病。遗传性眼病引起的视觉功能丧失通常很难通过传统的手术、激光治疗和局部药物治疗来治愈。基因治疗已成为治疗这类疾 病最重要的手段。腺相关病毒(AAV)由于具有安全性好、免疫原性低、表达时间长、有多种组织和细胞特异性血清型可选 择、高稳定性等优势,已被广泛应用于眼科疾病基因治疗。首款获批上市的遗传性视网膜疾病基因治疗药物 Luxturna(约 85 万 美元/剂)采用了 AAV

    • 纳米抗体开发及案例分享

      表达 表达时易形成包涵体,互相沾粘聚集沉淀。 表达量高,表达的抗体具有高水溶性,易复性。 抗体稳定性 易失活,高温或极度PH下失效或分解 高稳定性,高耐性,90℃处理后依然保持较高的活性 免疫原性 较高 较低 组织穿透力 较低 较高,可穿透血脑屏障 半衰期 较长 较短,血清清除速度快 纳米抗体序列优化纳米抗体 VHH

    图标技术资料

    需要更多技术资料 索取更多技术资料

    资料下载:

    biosyn_Vacmune.pdf 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2052
    广州威佳科技有限公司
    2025年07月12日询价
    询价
    北京诺博莱德科技有限公司
    2025年07月14日询价
    询价
    北京云肽生物科技有限公司
    2025年07月16日询价
    ¥3744
    上海经科化学科技有限公司
    2026年03月29日询价
    询价
    上海壹科繁生物科技有限公司
    2026年01月26日询价
    免疫级别血蓝蛋白
    ¥2000